FI970229A - Uusi menetelmä aktiivisen dimeerisen proteiinin valmistamiseksi - Google Patents

Uusi menetelmä aktiivisen dimeerisen proteiinin valmistamiseksi Download PDF

Info

Publication number
FI970229A
FI970229A FI970229A FI970229A FI970229A FI 970229 A FI970229 A FI 970229A FI 970229 A FI970229 A FI 970229A FI 970229 A FI970229 A FI 970229A FI 970229 A FI970229 A FI 970229A
Authority
FI
Finland
Prior art keywords
preparing
new method
dimeric protein
active dimeric
protein
Prior art date
Application number
FI970229A
Other languages
English (en)
Swedish (sv)
Other versions
FI970229A0 (fi
FI118083B (fi
Inventor
Nico Cerletti
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI970229A0 publication Critical patent/FI970229A0/fi
Publication of FI970229A publication Critical patent/FI970229A/fi
Application granted granted Critical
Publication of FI118083B publication Critical patent/FI118083B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI970229A 1994-07-25 1997-01-20 Uusi menetelmä biologisesti aktiivisen dimeerisen proteiinin valmistamiseksi FI118083B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP94810438 1994-07-25
EP94810438 1994-07-25
EP9502718 1995-07-12
PCT/EP1995/002718 WO1996003432A1 (en) 1994-07-25 1995-07-12 Novel process for the production of biologically active dimeric protein

Publications (3)

Publication Number Publication Date
FI970229A0 FI970229A0 (fi) 1997-01-20
FI970229A true FI970229A (fi) 1997-01-20
FI118083B FI118083B (fi) 2007-06-29

Family

ID=8218292

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970229A FI118083B (fi) 1994-07-25 1997-01-20 Uusi menetelmä biologisesti aktiivisen dimeerisen proteiinin valmistamiseksi

Country Status (19)

Country Link
US (1) US6057430A (fi)
EP (1) EP0775159B1 (fi)
JP (2) JP3923516B2 (fi)
KR (1) KR100432839B1 (fi)
AT (1) ATE207933T1 (fi)
AU (1) AU690311B2 (fi)
CA (1) CA2194582C (fi)
DE (1) DE69523605T2 (fi)
DK (1) DK0775159T3 (fi)
ES (1) ES2166401T3 (fi)
FI (1) FI118083B (fi)
HU (1) HU222830B1 (fi)
IL (1) IL114701A (fi)
NO (1) NO316926B1 (fi)
NZ (1) NZ290373A (fi)
PT (1) PT775159E (fi)
TW (1) TW440566B (fi)
WO (1) WO1996003432A1 (fi)
ZA (1) ZA956138B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW517059B (en) * 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
DE69636739T2 (de) * 1995-12-21 2007-10-18 Ajinomoto Co., Inc. Verfahren zur rückfaltung von menschlichem activin a
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
US20030120042A1 (en) * 2000-03-30 2003-06-26 Takao Yamada Process for producing recombinant protein
WO2001072331A1 (en) * 2000-03-31 2001-10-04 Vaccine Chip Technology Aps Immunostimulating properties of a fragment of tgf-beta
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
GB0514262D0 (en) * 2005-07-12 2005-08-17 Renovo Ltd Promotion of epithelial regeneration
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
GB0617816D0 (en) * 2006-09-11 2006-10-18 Renovo Ltd Nucleic acids and methods of protein expression
US8986769B2 (en) 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
EP3562839A4 (en) 2016-12-30 2020-09-02 Biogend Therapeutics Co., Ltd. RECOMBINANT POLYPEPTIDES, ASSOCIATED COMPOSITIONS AND PROCESSES
AU2019344801A1 (en) * 2018-09-17 2021-05-20 Board Of Regents, The University Of Texas System Compositions and methods for treating bone injury

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731440A (en) * 1985-02-22 1988-03-15 Monsanto Company Method of somatotropin solubilization using dimethylsulfone and naturation
JPH0759598B2 (ja) * 1986-02-14 1995-06-28 藤沢薬品工業株式会社 ヒトインスリン様成長因子▲ｉ▼の製造法
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
US5061786A (en) * 1989-05-25 1991-10-29 Genentech, Inc. Biologically active polypeptides based on transforming growth factor-β
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5144006A (en) * 1991-06-13 1992-09-01 The Rockefeller University Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides
AU2738392A (en) * 1991-11-11 1993-05-13 Ciba-Geigy Ag Novel hybrid transforming growth factors

Also Published As

Publication number Publication date
ZA956138B (en) 1996-03-07
FI970229A0 (fi) 1997-01-20
AU3109595A (en) 1996-02-22
JP3923516B2 (ja) 2007-06-06
DE69523605D1 (de) 2001-12-06
HUT76668A (en) 1997-10-28
IL114701A0 (en) 1995-11-27
WO1996003432A1 (en) 1996-02-08
JPH11505506A (ja) 1999-05-21
CA2194582A1 (en) 1996-02-08
NZ290373A (en) 1998-04-27
ATE207933T1 (de) 2001-11-15
ES2166401T3 (es) 2002-04-16
HU222830B1 (hu) 2003-11-28
NO970325L (no) 1997-03-06
EP0775159B1 (en) 2001-10-31
EP0775159A1 (en) 1997-05-28
AU690311B2 (en) 1998-04-23
NO316926B1 (no) 2004-06-28
DK0775159T3 (da) 2002-02-11
US6057430A (en) 2000-05-02
TW440566B (en) 2001-06-16
IL114701A (en) 2005-11-20
FI118083B (fi) 2007-06-29
PT775159E (pt) 2002-04-29
KR100432839B1 (ko) 2004-08-30
DE69523605T2 (de) 2002-07-11
NO970325D0 (no) 1997-01-24
JP2007031453A (ja) 2007-02-08
CA2194582C (en) 2008-09-02

Similar Documents

Publication Publication Date Title
FI970229A (fi) Uusi menetelmä aktiivisen dimeerisen proteiinin valmistamiseksi
FI970258A0 (fi) Uusi menetelmä biologisesti aktiivisen proteiinin valmistamiseksi
UA43348C2 (uk) Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
DE69739035D1 (de) Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
DE69023648D1 (de) Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung.
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
NZ325235A (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
DE3767977D1 (de) Lacton-abbauprodukt, verfahren zu dessen herstellung und dessen verwendung.
BG101570A (en) Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
PL355852A1 (en) Fragments of virus protein vp2 or 3 of the polyoma virus, used for transporting active ingredients
FR2766489B1 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
TR199802452T2 (xx) Potasyum klavulanat�n preparasyonu i�in geli�tirilmi� bir proses.
MX9700657A (es) Nuevo proceso para la produccion de proteina biologicamente activa.
MX9700656A (es) Proceso novedoso para la produccion de proteina dimerica biologicamente activa.
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
ES2004734A6 (es) Procedimiento de obtencion de conjugados biologicamente activos de metaloproteina-albumina o metaloproteina-albumina-anticuerpos
UA43374C2 (uk) Спосіб виготовлення хірургічного шовного матеріалу
ITRM940091A0 (it) Procedimento per la preparazione di colture cellulari di eisenia foetida (anellidi, oligocheti).
ES2171837T3 (es) Procedimiento para la preparacion de 2,3-piridindicarboximidas.
UA29770A (uk) Спосіб пригнічення репродукції вірусу імунодефіциту людини

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Ref document number: 118083

Country of ref document: FI